Evidence map›Paper›PMID 38741658›Full record

ArticleJAAD case reports2024

Tumor flare reaction in a patient with mycosis fungoides treated with a novel immune-epigenetic doublet.

Nakul Dar, Nathan Roberts, Alejandro Gru, Ifeyinwa Obiorah, Jiefu Zheng, Lale Kostakoglu Shields, Thomas Cropley, Enrica Marchi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JAAD case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nakul DarUniversity of Virginia School of Medicine, Charlottesville, Virginia.
Nathan RobertsDepartment of Hematology and Oncology, University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia.
Alejandro GruDepartment of Dermatology, Columbia University Irvine Medical Center, New York, New York.
Ifeyinwa ObiorahDepartment of Pathology, University of Virginia Medical Center, Charlottesville, Virginia.
Jiefu ZhengDepartment of Radiology and Medical Imaging, University of Virginia Medical Center, Charlottesville, Virginia.
Lale Kostakoglu ShieldsDepartment of Radiology and Medical Imaging, University of Virginia Medical Center, Charlottesville, Virginia.
Thomas CropleyDepartment of Dermatology, University of Virginia Medical Center, Charlottesville, Virginia.
Enrica MarchiDepartment of Hematology and Oncology, University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

aggressive non-Hodgkin's lymphomacell therapy and immunotherapycutaneous T-cell lymphomaflare reactionlymphoproliferative disordersmycosis fungoidespembrolizumab

Identifiers

PMID38741658
PMCPMC11090057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.